Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with Pseudomonas Airway Infection

Rationale: Fosfomycin/tobramycin for inhalation (FTI), a unique, broad-spectrum antibiotic combination, may have therapeutic potential for patients with cystic fibrosis (CF). Objectives: To evaluate safety and efficacy of FTI (160/40 mg or 80/20 mg), administered twice daily for 28 days versus place...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Trapnell, Bruce C., McColley, Susanna A., Kissner, Dana G., Rolfe, Mark W., Rosen, Jonathan M., McKevitt, Matthew, Moorehead, Lisa, Montgomery, A. Bruce, Geller, David E.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Thoracic Society 2012
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3361752/
https://ncbi.nlm.nih.gov/pubmed/22095545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201105-0924OC
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky